A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Belinostat (Primary) ; Zidovudine (Primary) ; Interferon alpha-2b
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2016 Planned primary completion date changed from 1 Aug 2021 to 1 Nov 2021.
- 14 Nov 2016 Status changed from not yet recruiting to recruiting.
- 20 Jul 2016 Planned primary completion date changed from 1 Mar 2021 to 1 Aug 2021.